tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market

Cyclo Therapeutics (CYTH) Ownership - Who Owns Cyclo Therapeutics?

Compare
236 Followers

Cyclo Therapeutics (CYTH) Ownership Overview

54.01%2.57%2.41%2.25%38.76%
54.01% Insiders
2.41% Other Institutional Investors
2.25% ETFs
38.76% Public Companies and
Individual Investors
The ownership structure of Cyclo Therapeutics (CYTH) stock is a mix of institutional, retail, and individual investors. Approximately 7.22% of the company’s stock is owned by Institutional Investors, 54.01% is owned by Insiders, and 38.76% is owned by Public Companies and Individual Investors.
The ownership structure of Cyclo Therapeutics (CYTH) stock is a mix of institutional, retail, and individual investors. Approximately 4.98% of the company’s stock is owned by Institutional Investors, 54.01% is owned by Insiders, and 2.25% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
12,998,194Insider45.43%13,518,122
743,804Insider2.60%773,556
598,694Institution2.09%622,642
598,694Institution2.09%622,642
382,122Insider1.34%397,407
369,103Insider1.29%383,867
348,771Insider1.22%362,722
148,826Insider0.52%154,779
145,826Insider0.51%151,659
135,655Institution0.47%141,081

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
598,694Institution2.09%622,642
135,655Institution0.47%141,081
623Institution<0.01%648

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
437,611Institution1.53%258,190
161,083Institution0.56%95,039
44,217Institution0.15%45,986

FAQ

Who Owns Cyclo Therapeutics (CYTH)?
According to the latest TipRanks data, approximately 2.41% of the company's stock is held by institutional investors, 54.01% is held by insiders, and 38.76% is held by retail investors.
    What percentage of Cyclo Therapeutics (CYTH) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.41% of Cyclo Therapeutics (CYTH) stock is held by institutional investors.
      What percentage of Cyclo Therapeutics (CYTH) stock is held by retail investors?
      According to the latest TipRanks data, approximately 38.76% of Cyclo Therapeutics (CYTH) stock is held by retail investors.
        Who owns the most shares of Cyclo Therapeutics (CYTH)?
        Rafael Holdings, Inc. owns the most shares of Cyclo Therapeutics (CYTH).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis